These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28499268)

  • 1. First universal pharmacophore model for hERG1 K
    Durdagi S; Erol I; Salmas RE; Patterson M; Noskov SY
    J Mol Graph Model; 2017 Jun; 74():153-170. PubMed ID: 28499268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S; Duff HJ; Noskov SY
    J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
    Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
    Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ
    PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive Saturation Simulations.
    Mousaei M; Kudaibergenova M; MacKerell AD; Noskov S
    J Chem Inf Model; 2020 Dec; 60(12):6489-6501. PubMed ID: 33196188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations.
    Subbotina J; Yarov-Yarovoy V; Lees-Miller J; Durdagi S; Guo J; Duff HJ; Noskov SY
    Proteins; 2010 Nov; 78(14):2922-34. PubMed ID: 20740484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural investigation of vesnarinone at the pore domains of open and open-inactivated states of hERG1 K
    Kayık G; Tüzün NŞ; Durdagi S
    J Mol Graph Model; 2017 Oct; 77():399-412. PubMed ID: 28963955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovery of potential ATP-sensitive potassium channel openers with potential hypotensive activity from Chinese herbs based on molecular simulation].
    Li Y; Jiang LD; Chen X; He YS; Li GY; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):264-271. PubMed ID: 28861972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
    Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
    J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining structure- and ligand-based approaches for studies of interactions between different conformations of the hERG K+ channel pore and known ligands.
    Coi A; Bianucci AM
    J Mol Graph Model; 2013 Nov; 46():93-104. PubMed ID: 24185260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of interaction mechanism of hERG1 potassium channel with scorpion toxins BeKm-1 and BmTx3b.
    Gunay BC; Yurtsever M; Durdagi S
    J Mol Graph Model; 2020 May; 96():107504. PubMed ID: 31901677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.
    Mo SL; Liu WF; Li CG; Zhou ZW; Luo HB; Chew H; Liang J; Zhou SF
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1640-704. PubMed ID: 22039821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.